Ident. | Authors (with country if any) | Title |
---|
000253 |
Sophia Zoungas [Australie] ; Mark Woodward [Australie, États-Unis] ; QIANG LI [Australie] ; Mark E. Cooper [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Michel Marre [France] ; Anushka Patel [Australie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie] | Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes |
000344 |
Paul Welsh [Royaume-Uni] ; Mark Woodward [Australie] ; Graham S. Hillis [Australie] ; QIANG LI [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Louise Ryan [Australie] ; Stephen Harrap [Australie] ; Ansuhka Patel [Australie] ; John Chalmers [Australie] ; Naveed Sattar [Royaume-Uni] | Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial |
000402 |
Gordon Lowe [Royaume-Uni] ; Mark Woodward [Australie] ; Graham Hillis [Australie] ; Ann Rumley [Royaume-Uni] ; QIANG LI [Australie] ; Stephen Harrap [Australie] ; Michel Marre [France] ; Pavel Hamet [Canada] ; Anushka Patel [Australie] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie] | Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study |
000588 |
Jamie Morton [Australie] ; Martin K. C. Ng [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Giuseppe Mancia [Italie] ; Neil R. Poulter [Royaume-Uni] ; Michel Marre [France] ; Mark E. Cooper [Australie] ; Sophia Zoungas [Australie] | The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? |
000692 |
Craig S. Anderson [Australie] ; Emma Heeley [Australie] ; YINING HUANG [République populaire de Chine] ; JIGUANG WANG [République populaire de Chine] ; Christian Stapf [France] ; Candice Delcourt [Australie] ; Richard Lindley [Australie] ; Thompson Robinson [Royaume-Uni] ; Pablo Lavados [Chili] ; Bruce Neal [Australie] ; Jun Hata [Australie, Japon] ; Hisatomi Arima [Australie] ; Mark Parsons [Australie] ; YUECHUN LI ; JINCHAO WANG [République populaire de Chine] ; Stephane Heritier [Australie] ; QIANG LI [Australie] ; Mark Woodward [Australie, États-Unis] ; R. John Simes [Australie] ; Stephen M. Davis [Australie] ; John Chalmers [Australie] | Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage |
000A91 |
Pamela M. Rist [États-Unis] ; John Chalmers [Australie] ; Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Stephen Macmahon [Australie] ; Mark Woodward [Australie] ; Tobias Kurth [États-Unis, France] ; Christophe Tzourio [France] | Baseline Cognitive Function, Recurrent Stroke, and Risk of Dementia in Patients With Stroke |
000E47 |
Meg J. Jardine [Australie] ; Jun Hata [Australie] ; Mark Woodward [Australie] ; Vlado Perkovic [Australie] ; Toshiharu Ninomiya [Australie] ; Hisatomi Arima [Australie] ; Sophia Zoungas [Australie] ; Alan Cass [Australie] ; Anushka Patel [Australie] ; Michel Marre [France] ; Giuseppe Mancia [Italie] ; Carl E. Mogensen [Danemark] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie] | Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes |
001179 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial |
001340 |
Bakhtawar K. Mahmoodi [États-Unis, Pays-Bas] ; Kunihiro Matsushita [États-Unis] ; Mark Woodward [États-Unis, Australie] ; Pester Blankestijn [Pays-Bas] ; Massimo Cirillo [Italie] ; Takayoshi Ohkubo [Japon] ; Peter Rossing [Danemark] ; Mark J. Sarnak [États-Unis] ; Benedicte Stengel [France] ; Kazumasa Yamagishi [Japon] ; Kentaro Yamashita [Japon] ; LUXIA ZHANG [République populaire de Chine] ; Josef Coresh [États-Unis] ; Paul E. De Jong [Pays-Bas] ; Brad C. Astor [États-Unis] | Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis |
001559 |
Mark Woodward [Royaume-Uni, États-Unis, Australie] ; Hugh Tunstall-Pedoe [Royaume-Uni] ; G. David Batty [Royaume-Uni] ; Roger Tavendale [Royaume-Uni] ; Frank B. Hu [États-Unis] ; Sebastien Czernichow [France] | The prognostic value of adipose tissue fatty acids for incident cardiovascular disease: results from 3944 subjects in the Scottish Heart Health Extended Cohort Study |
001577 |
Sébastien Czernichow [Australie, France] ; Alberto Zanchetti [Italie] ; Fiona Turnbull [Australie] ; Federica Barzi [Australie] ; Toshiaru Ninomiya [Australie] ; André-Pascal Kengne [Australie] ; Hiddo J. Lambers Heerspink [Pays-Bas] ; Vlado Perkovic [Australie] ; Rachel Huxley [Australie] ; Hisatomi Arima [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials |
001660 |
Daniel G. Hackam [Canada] ; Mark Woodward [Australie] ; L. Kristin Newby [États-Unis] ; Deepak L. Bhatt [États-Unis] ; Mingyuan Shao [États-Unis] ; Eric E. Smith [Canada] ; Allan Donner [Canada] ; Muhammad Mamdani [Canada] ; James D. Douketis [Canada] ; Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; David L. Tirschwell [États-Unis] ; Bruce M. Psaty [États-Unis] ; Cheryl D. Bushnell [États-Unis] ; Maria I. Aguilar [États-Unis] ; Dan J. Capampangan [États-Unis] ; David J. Werring [Royaume-Uni] ; Paola De Rango [Italie] ; Anand Viswanathan [États-Unis] ; Nicolas Danchin [France] ; Ching-Lan Cheng [Taïwan] ; Yea-Huei Kao Yang [Taïwan] ; B. Marianne Verdel [Pays-Bas] ; Mei-Shu Lai [Taïwan] ; James Kennedy [Royaume-Uni] ; Shinichiro Uchiyama [Japon] ; Takenori Yamaguchi [Japon] ; Yasuo Ikeda [Japon] ; Marko Mrkobrada [Canada] | Statins and Intracerebral Hemorrhage Collaborative Systematic Review and Meta-Analysis |
001955 |
Rachel R. Huxley [Australie, États-Unis] ; Federica Barzi [Australie] ; TAI HING LAM [Hong Kong] ; Sebastien Czernichow [Australie, France] ; XIANGHUA FANG [République populaire de Chine] ; Tim Welborn [Australie] ; Jonathan Shaw [Australie] ; Hirotsugu Ueshima [Japon] ; Paul Zimmet [Australie] ; Sun Ha Jee [Corée du Sud] ; Jeetesh V. Patel [Royaume-Uni] ; Ian Caterson [Australie] ; Vlado Perkovic [Australie] ; Mark Woodward [Australie, États-Unis] | Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region |
002042 |
Sophia Zoungas [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; QIANG LI [Australie] ; M. Biostat [Australie] ; Laurent Billot [Australie] ; Mark Woodward [États-Unis] ; Toshiharu Ninomiya [Australie] ; Bruce Neal [Australie] ; Stephen Macmahon [Australie] ; Diederick E. Grobbee [Pays-Bas] ; Andre Pascal Kengne [Australie] ; Michel Marre [France] ; Simon Heller [Royaume-Uni] | Severe Hypoglycemia and Risks of Vascular Events and Death |
002158 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie] | Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial |
002339 |
Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial |
002427 |
G. David Batty [Royaume-Uni, Australie] ; QIANG LI [Australie] ; Sébastien Czernichow [Australie, France] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Rachel Huxley [Australie] ; Anushka Patel [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Mark Woodward [Australie, États-Unis] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie] | Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial |
002461 |
Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Craig Anderson [Australie] ; Mark Woodward [États-Unis] ; Marie-Germaine Bousser [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial |
002A19 |
Bastiaan E. De Galan [Australie, Pays-Bas] ; Vlado Perkovic [Australie] ; Toshiharu Ninomiya [Australie] ; Avinesh Pillai [Australie] ; Anushka Patel [Australie] ; Alan Cass [Australie] ; Bruce Neal [Australie] ; Neil Poulter [Royaume-Uni] ; Stephen Harrap [Australie] ; Carl-Erik Mogensen [Danemark] ; Mark Cooper [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Pavel Hamet [Canada] ; Giuseppe Mancia [Italie] ; Mark Woodward [Australie] ; Paul Glasziou [Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] | Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes |
002C37 |
Sophia Zoungas [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Diederick Grobbee [Pays-Bas] ; Pavel Hamet [Canada] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Australie] ; Michel Marre [France] ; Bruce Neal [Australie] ; Anushka Patel [Australie] ; Mark Woodward [Australie, États-Unis] ; John Chalmers [Australie] | Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial |
002C40 |
Rachel Huxley [Australie] ; Crystal Man Ying Lee [Australie] ; Federica Barzi [Australie] ; Leif Timmermeister [Australie] ; Sebastien Czernichow [Australie, France] ; Vlado Perkovic [Australie] ; Diederick E. Grobbee [Pays-Bas] ; David Batty [Australie, Royaume-Uni] ; Mark Woodward [Australie, États-Unis] | Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus: A Systematic Review With Meta-analysis |
002C66 |
Andre-Pascal Kengne [Australie] ; Sébastien Czernichow [France] ; Rachel Huxley [Australie] ; Diederick Grobbee [Pays-Bas] ; Mark Woodward [États-Unis] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Mark Cooper [Australie] ; Paul Glasziou [Royaume-Uni] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie] | Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE |
002D01 |
Toshiharu Ninomiya [Australie] ; Vlado Perkovic [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Sophia Zoungas [Australie] ; Avinesh Pillai [Australie] ; Meg Jardine [Australie] ; Anushka Patel [Australie] ; Alan Cass [Australie] ; Bruce Neal [Australie] ; Neil Poulter [Royaume-Uni] ; Carl-Erik Mogensen [Danemark] ; Mark Cooper [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Pavel Hamet [Canada] ; Giuseppe Mancia [Italie] ; Mark Woodward [Australie, États-Unis] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] | Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes |
003D54 |
Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Ken Butcher [Australie] ; Craig Anderson [Australie] ; Marie-Germaine Bousser [France] ; Kennedy R. Lees [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] | Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial |
003F04 |
Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial |
004446 |
Pierre Amarenco [France] ; Anushka Patel [France] ; Mark Woodward [France] ; Duncan J. Campbell [Australie] ; David R. Sullivan [Australie] ; Samuel Colman [France] ; John Chalmers [France] ; Bruce Neal [France] ; Stephen Macmahon [France] | Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease |
004640 |
Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie] | Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy |
004A11 |
Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France] | Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary |
004D83 |
Stephen B. Harrap [Australie] ; Christophe Tzourio [France] ; Francois Cambien [France] ; Odette Poirier [France] ; Segolene Raoux [France] ; John Chalmers [Australie] ; Neil Chapman [Australie] ; Samuel Colman [Australie] ; Solenn Leguennec [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Takayoshi Ohkubo [Australie] ; Mark Woodward [Australie] | The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition |
004F96 |
Armin Imhof [Allemagne] ; Margit Fröhlich [Allemagne] ; Hannelore Loewel [Allemagne] ; Nicole Helbecqae [France] ; Mark Woodward [Australie] ; Phillipe Amouyel [France] ; Gordon D. O. Lowe [Royaume-Uni] ; Wolfgang Koenig [Allemagne] | Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe |